FBN1 and aortic aneurysm: By linking a clinically relevant FBN1 mutation to aneurysm pathology, this model enables mechanistic investigation of extracellular matrix–based drivers of aneurysm progression and supports the evaluation of therapeutic strategies aimed at stabilizing the aortic wall in aortic aneurysm diseases.